Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report

We report a case of a 24-year-old man who developed angioimmunoblastic T-cell lymphoma (AITL) after treatment for refractory lymphocyte-rich classic Hodgkin lymphoma (LR-CHL). This patient was treated with the BV+AVD (brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) protocol for LR-CH...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ken Tanaka, Hiroaki Miyoshi, Yusuke Yamashita, Ryuta Iwamoto, Yuma Yokoya, Yuichi Tochino, Fumiko Arakawa, Shinobu Tamura, Shin-Ichi Murata, Takashi Sonoki, Koichi Ohshima
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-11-01
Serie:	Hematology Reports
Soggetti:	classic hodgkin lymphoma lymphocyte rich classic hodgkin lymphoma angioimmunoblastic T-cell lymphoma secondary non-hodgkin lymphoma
Accesso online:	https://www.mdpi.com/2038-8330/15/4/67
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!